Skip to content

Orexigen Therapeutics, Inc.

Delisted

CIK 1382911fmd_0P4R2YN2D327Z01VMVM6FVNJVAManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2017, 31 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading